SYNTHESIS OF NOVEL ANDROGEN-LINKED PHOSPHORAMIDE MUSTARD PRODRUGS ANDGROWTH-INHIBITORY ACTIVITY IN HUMAN BREAST-CANCER CELLS

Citation
T. Roth et al., SYNTHESIS OF NOVEL ANDROGEN-LINKED PHOSPHORAMIDE MUSTARD PRODRUGS ANDGROWTH-INHIBITORY ACTIVITY IN HUMAN BREAST-CANCER CELLS, Anti-cancer drug design, 10(8), 1995, pp. 655-666
Citations number
22
Categorie Soggetti
Pharmacology & Pharmacy",Oncology,Biology
Journal title
ISSN journal
02669536
Volume
10
Issue
8
Year of publication
1995
Pages
655 - 666
Database
ISI
SICI code
0266-9536(1995)10:8<655:SONAPM>2.0.ZU;2-P
Abstract
Two steroid-linked phosphoramide mustard prodrugs, 7a and 7b, were syn thesized. The androgens testosterone and 19-nortestosterone were linke d through the 17 beta-position via an acetal bond to aldophosphamide ( 3). Proton-catalyzed, as well as cytochrome P450-mediated cleavage of the acetal bond resulted in the release of 3 which decays into the ult imate cytotoxic species, phosphoramide mustard. In a competitive cellu lar binding assay, the new prodrugs displayed similar to 10-12% affini ty to androgen binding proteins in breast cancer cells, relative to te stosterone (100%). In the sex hormone receptor negative cell line MDA- MB231, the testosterone conjugate 7a and the 19-nortestosterone conjug ate 7b have been found to be as effective as 4-hydroperoxycyclophospha mide (5). Both compounds were more active than 5 in receptor-positive cell lines. No significant differences in response were observed, howe ver, between receptor-negative and receptor-positive cell lines.